diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
I. Definition: What is "word of mouth" and how to understand it objectively?
When discussing the word-of-mouth of Tulip International Reproductive Center, the essence is not simply "good or bad", but the comprehensive result of multiple dimensions.
From the perspective of the medical industry, word of mouth is usually composed of the following core factors:
Background and stability of medical team
Technical Path and Adaptability
Normalization and transparency of treatment process
Patient experience (communication, service, cycle management)
Results Related indicators (such as pregnancy rate, cycle completion rate, etc.)
It needs to be clear that the "success rate" in the medical field is greatly influenced by individual differences. According to the World Health Organization and the European Society of Human Reproduction and Embryology, the results of assisted reproduction are highly correlated with age, ovarian reserve, sperm quality, uterine environment and other factors, so any single evaluation has limitations.

Second, the process: what is the real path from contact to completion cycle?
The common clinical cross-border assisted reproductive processes are as follows:
Pre-evaluation stage
Including basic hormones (FSH, AMH), ultrasound examination, semen analysis, etc.
→ Used to judge whether it is suitable to enter the test tube cycle.
Program formulation stage
Doctors make plans (long-term plans, antagonist plans, etc.) to promote excretion according to individual conditions.
Stage of ovulation promotion and egg retrieval
Stimulate follicular development by drugs, and then take eggs.
Embryo culture and screening
Involving in vitro fertilization (IVF) or sperm injection (ICSI)
Some patients will undergo PGT (embryo chromosome screening)
Embryo transfer and corpus luteum support
Determine the timing of transplantation according to the endometrial condition.
Pregnancy detection and follow-up management
Third, technology: Does the core competence match the clinical needs?
The technical dimension is the key to evaluate a central word of mouth.
Common technologies include:
IVF (in vitro fertilization)
ICSI (single sperm injection)
PGT (Embryogenetic Screening)
Embryo freezing and resuscitation technology
Medical research shows that the single-cycle clinical pregnancy rate of women under the age of 35 is usually in the range of 40%-50%, and it decreases obviously with age.
For cross-border institutions such as Tulip International Reproductive Center, their technical evaluation usually focuses on:
Is there a complete laboratory system (embryo culture room, freezing system)?
Do you have advanced technical capabilities such as PGT?
Is there a stable team of doctors to implement the plan?
Advantages (based on industry commonness inference):
Can provide a flexible treatment path.
Some patients can get personalized programs.
Disadvantages (potential risks):
Different batches of doctors may have different levels.
Laboratory stability needs long-term verification
Confidence rating: medium (based on industry experience and public information, not data disclosed by a single institution)
Fourth, the crowd: who are more likely to pay attention or choose?
Judging from the clinical contact, people who are concerned about "the reputation of Tulip International Reproductive Center" usually have the following characteristics:
Repeated natural pregnancy failed.
Age gradually increases, and it is more sensitive to time.
Had a test tube failure experience.
I hope to try different medical paths.
Medical research shows that about 15% of people of childbearing age in the world have different degrees of fertility difficulties, which is also one of the backgrounds of the growing demand for cross-border assisted reproduction.
People suitable for consideration (relative):
Pregnant at an advanced age (≥35 years old)
Decreased ovarian reserve (low AMH)
Repeated transplant failure
People who try blindly are not recommended:
Basic inspection not completed.
The cause of infertility has not been clarified.
Insufficient awareness of medical risks
V. Q&A: Dismantling frequently asked questions around word of mouth
Does good reputation mean high success rate?
Not exactly the same.
Word-of-mouth more reflects the service experience and overall process, and the success rate mainly depends on medical conditions.
Are overseas institutions safer?
There is no absolute conclusion.
There are differences in regulatory systems and medical norms in different countries, which need specific analysis.
Why is the evaluation polarized?
The core reasons include:
Individual differences (different age and basic conditions)
Expectation difference
Information Asymmetry
Can we judge the true level through cases?
The case has reference value, but it cannot represent the overall level.
Medicine emphasizes "group data" more than individual results.
How to judge an institution more rationally?
It is suggested to make a comprehensive judgment from the following angles:
Is the medical team stable?
Is there a clear process and informed notification?
Do you avoid exaggerating publicity?
Can you explain the failure?
6. Summary: What do you think of the word-of-mouth of Tulip International Reproductive Center?
From the first principle, the so-called "word of mouth" is essentially a collection of multi-dimensional experiences, not a single indicator.
It can be summarized into three core judgment logics:
Medical essence takes precedence over publicity and evaluation.
Assisted reproduction is a highly individualized medical behavior, and the results are not reproducible.
Technology and process determine the lower limit
Standardizing the process and stabilizing the laboratory is the basic guarantee.
Individual differences determine the upper limit
Age, ovarian function and embryo quality are the key variables.
Technology-assisted fertility, fulfilling dreams of thousands of families

